GSG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.667600E-01
Normal-vs-Stage2
5.796800E-01
Normal-vs-Stage3
4.006800E-01
Normal-vs-Stage4
4.391400E-01
Stage1-vs-Stage2
3.658600E-01
Stage1-vs-Stage3
5.471000E-01
Stage1-vs-Stage4
8.119200E-01
Stage2-vs-Stage3
2.236200E-01
Stage2-vs-Stage4
3.447600E-01
Stage3-vs-Stage4
7.055800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.634400E-01
Normal-vs-AfricanAmerican
4.638600E-01
Normal-vs-Asian
4.993000E-01
Caucasian-vs-AfricanAmerican
9.714400E-02
Caucasian-vs-Asian
4.978200E-01
AfricanAmerican-vs-Asian
7.166800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.279200E-01
Normal-vs-Female
5.843800E-01
Male-vs-Female
2.792800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.934000E-01
Normal-vs-Age(41-60Yrs)
6.062000E-01
Normal-vs-Age(61-80Yrs)
5.246600E-01
Normal-vs-Age(81-100Yrs)
6.247200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.432600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.704600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.931700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.200200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.549600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.224800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.705800E-01
Normal-vs-Daily Drinker
5.020400E-01
Normal-vs-Weekly Drinker
7.136400E-01
Normal-vs-Occasional Drinker
5.443000E-01
Normal-vs-Social Drinker
5.703800E-01
Non Drinker-vs-Daily Drinker
3.854000E-01
Non Drinker-vs-Weekly Drinker
5.127000E-01
Non Drinker-vs-Occasional Drinker
7.634600E-01
Non Drinker-vs-Social Drinker
9.931800E-01
Daily Drinker-vs-Weekly Drinker
3.368400E-01
Daily Drinker-vs-Occasional Drinker
6.004000E-01
Daily Drinker-vs-Social Drinker
3.493600E-01
Weekly Drinker-vs-Occasional Drinker
4.441400E-01
Weekly Drinker-vs-Social Drinker
5.092000E-01
Occasional Drinker-vs-Social Drinker
7.390600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.574600E-01
Normal-vs-Grade 2
5.888000E-01
Normal-vs-Grade 3
5.945600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.956400E-03
Grade 1-vs-Grade 3
5.759300E-03
Grade 1-vs-Grade 4
5.574600E-01
Grade 2-vs-Grade 3
5.767000E-01
Grade 2-vs-Grade 4
5.888000E-01
Grade 3-vs-Grade 4
5.945600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.426600E-01
Normal-vs-NonDiabetic
5.491400E-01
Diabetic-vs-NonDiabetic
9.065800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.130200E-01
Normal-vs-NoPancreatitis
5.426200E-01
Pancreatitis-vs-NoPancreatitis
5.201400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.351400E-01
Normal-vs-N1
5.696000E-01
N0-vs-N1
5.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.014000E-01
Normal-vs-TP53-NonMutant
5.153200E-01
TP53-Mutant-vs-TP53-NonMutant
2.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
